This document provides an overview of general requirements for pharmaceutical manufacturing premises according to Good Manufacturing Practice (GMP) standards. It discusses location, design, construction, and maintenance of facilities. Specific areas covered include ancillary areas, storage areas, weighing rooms, production areas, and quality control laboratories. Key requirements addressed are preventing cross-contamination, permitting effective cleaning and maintenance, and controlling temperature, humidity and air quality. The document aims to help ensure premises are suitable for intended operations and manufacturing of quality products.
The document discusses the importance of environmental control in the pharmaceutical industry. It states that controlling factors like particulate matter, microorganisms, temperature, humidity and airflow is crucial to protecting pharmaceutical products from contamination. A properly designed, validated and monitored HVAC system is necessary to ensure quality and safety. The HVAC system controls air movement and distribution of temperature and humidity in cleanrooms to maintain suitable manufacturing conditions.
This document discusses cross-contamination, mix-ups, and clean room practices. It defines key terms like contamination, cross-contamination, and mix-ups. It identifies sources of contamination like personnel, equipment, airflow, and discusses prevention methods like facility design, cleaning validation, and cleanroom classification systems. Personnel clothing, hygiene, and cleaning practices are important to prevent contamination from people. Proper airflow and HVAC systems also help control contamination. Regular monitoring and maintenance of cleanrooms is necessary to ensure quality manufacturing of pharmaceutical products.
Hold-time studies establish the maximum acceptable time periods that materials at different stages of production can be held before processing to the next stage while still meeting quality acceptance criteria. The studies involve collecting data from pilot batches, process validation, or investigations to justify hold times. Manufacturers map out critical stages and potential pauses on a flow chart and conduct testing at intervals on samples stored under appropriate conditions. Test results are compared to acceptance limits, which are more stringent than specifications, to confirm the material remains well within control during the defined hold period.
This document discusses regulations regarding the manufacture of pharmaceutical products and active ingredients, including requirements for qualifying vendors that supply materials. Strict good manufacturing practices (GMP) are required to ensure quality, safety and efficacy. Vendor qualification is important to provide assurance of drug product performance and avoid risks like contamination. The document refers to other guidance on topics like quality agreements, auditing, and assessing vendor performance on supply assurance, quality, costs, and responsiveness. Packaging component supplier audits are also discussed.
Role of quality system and audits in pharmamaceuticalganpat420
Introduction
cGMP Regulations
Quality Assurance Function
Quality Systems Approach
Management Responsibilities
Resources
Manufacturing Operations
Evaluation Activities
Transitioning to Quality Systems Approach
Audit Checklist for Drug Industry
This document discusses air circulation maintenance in sterile and non-sterile pharmaceutical areas. It covers the importance of HVAC systems in maintaining air quality, including components like ducting, filters, and airflow patterns. Different classification systems are used for sterile versus non-sterile areas. HVAC systems can use either full fresh air or air recirculation with HEPA filters. Key parameters to monitor include filter integrity, air changes, pressure, microbial loads, temperature, and humidity. Proper air handling is crucial for pharmaceutical manufacturing to control contamination.
Line clearance is an important procedure to prevent mix-ups and mistakes during manufacturing. It involves three stages: clearing, cleaning, and checking. During clearing, materials from the previous production are removed. Next, cleaning is done according to standard operating procedures. Finally, the line is checked and any issues are recorded before clearance is given to begin the next production. Line clearance must be performed before various stages of production such as dispensing, filling, packaging, and more. It helps ensure safety and quality in manufacturing.
The document discusses the importance of environmental control in the pharmaceutical industry. It states that controlling factors like particulate matter, microorganisms, temperature, humidity and airflow is crucial to protecting pharmaceutical products from contamination. A properly designed, validated and monitored HVAC system is necessary to ensure quality and safety. The HVAC system controls air movement and distribution of temperature and humidity in cleanrooms to maintain suitable manufacturing conditions.
This document discusses cross-contamination, mix-ups, and clean room practices. It defines key terms like contamination, cross-contamination, and mix-ups. It identifies sources of contamination like personnel, equipment, airflow, and discusses prevention methods like facility design, cleaning validation, and cleanroom classification systems. Personnel clothing, hygiene, and cleaning practices are important to prevent contamination from people. Proper airflow and HVAC systems also help control contamination. Regular monitoring and maintenance of cleanrooms is necessary to ensure quality manufacturing of pharmaceutical products.
Hold-time studies establish the maximum acceptable time periods that materials at different stages of production can be held before processing to the next stage while still meeting quality acceptance criteria. The studies involve collecting data from pilot batches, process validation, or investigations to justify hold times. Manufacturers map out critical stages and potential pauses on a flow chart and conduct testing at intervals on samples stored under appropriate conditions. Test results are compared to acceptance limits, which are more stringent than specifications, to confirm the material remains well within control during the defined hold period.
This document discusses regulations regarding the manufacture of pharmaceutical products and active ingredients, including requirements for qualifying vendors that supply materials. Strict good manufacturing practices (GMP) are required to ensure quality, safety and efficacy. Vendor qualification is important to provide assurance of drug product performance and avoid risks like contamination. The document refers to other guidance on topics like quality agreements, auditing, and assessing vendor performance on supply assurance, quality, costs, and responsiveness. Packaging component supplier audits are also discussed.
Role of quality system and audits in pharmamaceuticalganpat420
Introduction
cGMP Regulations
Quality Assurance Function
Quality Systems Approach
Management Responsibilities
Resources
Manufacturing Operations
Evaluation Activities
Transitioning to Quality Systems Approach
Audit Checklist for Drug Industry
This document discusses air circulation maintenance in sterile and non-sterile pharmaceutical areas. It covers the importance of HVAC systems in maintaining air quality, including components like ducting, filters, and airflow patterns. Different classification systems are used for sterile versus non-sterile areas. HVAC systems can use either full fresh air or air recirculation with HEPA filters. Key parameters to monitor include filter integrity, air changes, pressure, microbial loads, temperature, and humidity. Proper air handling is crucial for pharmaceutical manufacturing to control contamination.
Line clearance is an important procedure to prevent mix-ups and mistakes during manufacturing. It involves three stages: clearing, cleaning, and checking. During clearing, materials from the previous production are removed. Next, cleaning is done according to standard operating procedures. Finally, the line is checked and any issues are recorded before clearance is given to begin the next production. Line clearance must be performed before various stages of production such as dispensing, filling, packaging, and more. It helps ensure safety and quality in manufacturing.
This document summarizes the validation process for a liquid filling and sealing machine. It discusses the key stages of validation including user requirement specification, design qualification, installation qualification, operational qualification, and performance qualification. It provides details on each stage, describing the objectives and tests performed at each stage. For example, performance qualification involves weight variation testing, filling volume accuracy testing, particle contamination testing, leak testing, and oxygen content testing to validate the machine's performance under working conditions. The overall validation process helps ensure the machine operates as intended and produces product meeting specifications.
The document discusses basic principles of sanitation and hygiene for good manufacturing practices (GMP). It outlines that high sanitation and hygiene must be practiced in all aspects of manufacturing, including personnel, premises, equipment, materials, and products. Personal hygiene measures include health examinations, training, illness reporting, and avoiding direct contact with products. Sanitary facilities and proper clothing are required. Premises must be designed to prevent dirt buildup and allow for effective cleaning. Cross-contamination is avoided through proper airflow, ventilation, and airlocks. Operations involve sanitizing water systems and conducting maintenance to avoid risks to products.
The document discusses the process of equipment qualification which includes design qualification (DQ), installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). DQ establishes that the equipment design meets predefined user requirements. IQ demonstrates that equipment has been properly installed. OQ shows that equipment can consistently operate within defined parameters. PQ shows that equipment can consistently meet performance standards under real-world conditions. The document provides details on the documentation and tests required for each qualification step.
c gmp (current good manufacturing practices)Rohit K.
cGMP (Current Good Manufacturing Practices) regulations provide the framework for ensuring quality control during pharmaceutical manufacturing. The regulations are divided into parts 210 and 211. Part 211 addresses good manufacturing practices for finished pharmaceuticals and is further divided into 11 subparts covering organization, facilities, equipment, production, packaging, labeling, quality control, and more. The goal of cGMP is to ensure identity, strength, quality and purity of drugs through strict control of manufacturing and monitoring.
Quality assurance maintenance of hvac system in pharmaceutical industryShahbazNadaf
The document discusses quality assurance maintenance of HVAC systems. It describes the importance of regularly maintaining HVAC systems to ensure consistent performance and longevity. Key aspects of HVAC maintenance include inspecting and changing air filters, cleaning debris, checking refrigerant levels, and lubricating moving parts. The document provides tips for maintenance schedules and lists 30 points to check during maintenance.
This document provides an overview of process automation in the pharmaceutical industry. It discusses various pharmaceutical manufacturing processes like granulation, drying, milling, and compression. It also describes different types of pharmaceutical processing equipment used for unit operations like mixing, drying, milling etc. Finally, it discusses process automation and concepts like cleaning-in-place and sterilization-in-place which are important for ensuring sterility in pharmaceutical manufacturing.
SUPAC, BACPAC, Post Marketing SurveillanceMANIKANDAN V
This document discusses various guidelines related to product development and technology transfer in the pharmaceutical industry. It covers SUPAC, BACPAC, and post-marketing surveillance. SUPAC provides guidance for scale-up and post-approval changes, categorizing changes into different levels based on their potential impact. BACPAC guidance addresses post-approval changes for bulk active pharmaceutical ingredients. Post-marketing surveillance involves monitoring adverse drug events after approval to ensure ongoing safety and effectiveness.
This document discusses the validation of a fluidized bed dryer. It begins with an introduction to fluidized bed drying and the construction and working of fluidized bed dryers. It then discusses the four stages of validation for equipment: design qualification, installation qualification, operational qualification, and performance qualification. For each stage, it provides details on the specific tests and documentation required for validating a fluidized bed dryer. It emphasizes establishing that the dryer will consistently and reliably perform its intended functions.
A brief presentation on the current good manufacturing practices employed in the manufacture of pharmaceuticals in the US.
Comprises of all aspects of good manufacturing practices
This document outlines the key concepts and history of the process validation lifecycle approach. It discusses the development of the approach through various regulatory guidances from organizations like FDA, Health Canada, EMA, ICH, and PIC/S. The lifecycle approach involves three stages: process design, process qualification, and continued process verification. It represents a shift from a traditional approach of conducting process validation to one focused on continual process improvement and understanding over the entire product lifecycle. Implementation of the approach can be difficult for organizations.
Auditing of vendors and production departmentPRANJAY PATIL
The document discusses vendor audits in the pharmaceutical industry. It provides details on the objectives, parameters, and steps of conducting a vendor audit. The key points are:
- Vendor audits assess a vendor's quality management system, practices, documentation, and adherence to standards to ensure their products and services meet requirements.
- Important parameters reviewed include ISO certifications, manufacturing facilities, packaging and labeling standards, and data handling procedures.
- The goals are to evaluate quality control measures and management commitment to quality standards required by regulations.
- Conducting vendor audits helps reduce costs and risks by gaining insight into supplier processes and compliance.
This document provides an overview of qualification and validation principles according to Good Manufacturing Practices (GMP). It defines qualification and validation, and explains their scope, principles, types of documentation, and importance. Qualification and validation provide documented evidence that critical aspects of manufacturing are controlled. The document outlines the key elements that should be addressed in a validation master plan, protocol, and report. It also discusses new approaches to validation including risk assessment and a three-phase process design.
Air Based Hazards, M.pharm, sem 2,Bhumi Suratiya,.pptxBhumiSuratiya
Air Based Hazard, M.Pharm, Sem 2,Bhumi Suratiya, Pharmaceutical Quality Assurance. Source of air based hazard, types of air based hazard, air circulation maintenance for sterile and non sterile area . Application of air circulation, HEPA filter, clean area classification.
The document discusses the pharmaceutical industry development process in India. It outlines the legal requirements and licenses needed to manufacture or import APIs and drugs. Companies must seek approval from the DCGI and adhere to CDSCO guidelines. The application process requires submitting chemical, pharmaceutical, pre-clinical and clinical data. Various forms are used for obtaining manufacturing, import, and sales licenses from the CDSCO. The CDSCO-SUGAM project aims to streamline approval processes.
Sanitization & Hygiene in PharmaceuticalIqra Shafeeq
This document discusses sanitation and hygiene in the pharmaceutical industry. It outlines the importance of high sanitation standards across all aspects of manufacturing, including personnel, premises, equipment, materials and products. Specific hygiene practices for personnel are described, such as health examinations, illness reporting, protective clothing, and restrictions on eating or smoking in production areas. Design of premises and avoidance of cross-contamination through measures like segregated areas, ventilation, airlocks, clothing standards and cleaning validation are also covered. Production operation sanitation procedures including cleaning validation, water systems cleaning and maintenance activities are summarized.
The document discusses plastic packaging materials used for pharmaceutical products. It begins by describing the two main categories of plastics - thermoplastics and thermosets. It then discusses potential interactions between drugs and plastic packaging, including permeation, leaching, sorption, and chemical reactions. Finally, it covers various closure and sealing methods that are approved by the FDA as tamper resistant packaging systems for pharmaceuticals, such as blister packs, bubble packs, foil/plastic pouches, and bottle seals.
This document provides information about qualification of an autoclave. It defines qualification as proving that equipment works correctly and leads to expected results. It discusses different types of qualification including design, installation, operational, and performance qualification. For autoclave qualification, it outlines tests that should be performed at each stage like temperature mapping, alarm checks, steam penetration tests, and biological indicator testing to prove the autoclave is sterilizing properly. It also provides guidelines for safe operation of the autoclave.
This document discusses good manufacturing practices for manufacturing operations and controls in the pharmaceutical industry. It covers several key topics:
1. Sanitation of manufacturing premises is important to ensure good hygiene of facilities, equipment, processes, and personnel. Cleaning and validation procedures should be established and records maintained.
2. Proper controls must be established to prevent mix-ups and cross-contamination during production. This includes separation of products, labeling, cleaning procedures, and qualified personnel.
3. Waste and scrap from manufacturing must be properly handled, collected, stored, and disposed of according to established guidelines. Hazardous and pharmaceutical wastes require special treatment and disposal.
Audit of vendors and production departmentSanmati shete
The document presents checklists for tableting, capsule filling, and sterile preparation processes. It was created by Sanmati Dilip Shete, an M.Pharm. student in the Department of Quality Assurance at Rajarambapu College of Pharmacy. The checklists provide steps to ensure quality control for common pharmaceutical manufacturing processes like tablet production, capsule filling, and sterile compounding.
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
This document summarizes the validation process for a liquid filling and sealing machine. It discusses the key stages of validation including user requirement specification, design qualification, installation qualification, operational qualification, and performance qualification. It provides details on each stage, describing the objectives and tests performed at each stage. For example, performance qualification involves weight variation testing, filling volume accuracy testing, particle contamination testing, leak testing, and oxygen content testing to validate the machine's performance under working conditions. The overall validation process helps ensure the machine operates as intended and produces product meeting specifications.
The document discusses basic principles of sanitation and hygiene for good manufacturing practices (GMP). It outlines that high sanitation and hygiene must be practiced in all aspects of manufacturing, including personnel, premises, equipment, materials, and products. Personal hygiene measures include health examinations, training, illness reporting, and avoiding direct contact with products. Sanitary facilities and proper clothing are required. Premises must be designed to prevent dirt buildup and allow for effective cleaning. Cross-contamination is avoided through proper airflow, ventilation, and airlocks. Operations involve sanitizing water systems and conducting maintenance to avoid risks to products.
The document discusses the process of equipment qualification which includes design qualification (DQ), installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). DQ establishes that the equipment design meets predefined user requirements. IQ demonstrates that equipment has been properly installed. OQ shows that equipment can consistently operate within defined parameters. PQ shows that equipment can consistently meet performance standards under real-world conditions. The document provides details on the documentation and tests required for each qualification step.
c gmp (current good manufacturing practices)Rohit K.
cGMP (Current Good Manufacturing Practices) regulations provide the framework for ensuring quality control during pharmaceutical manufacturing. The regulations are divided into parts 210 and 211. Part 211 addresses good manufacturing practices for finished pharmaceuticals and is further divided into 11 subparts covering organization, facilities, equipment, production, packaging, labeling, quality control, and more. The goal of cGMP is to ensure identity, strength, quality and purity of drugs through strict control of manufacturing and monitoring.
Quality assurance maintenance of hvac system in pharmaceutical industryShahbazNadaf
The document discusses quality assurance maintenance of HVAC systems. It describes the importance of regularly maintaining HVAC systems to ensure consistent performance and longevity. Key aspects of HVAC maintenance include inspecting and changing air filters, cleaning debris, checking refrigerant levels, and lubricating moving parts. The document provides tips for maintenance schedules and lists 30 points to check during maintenance.
This document provides an overview of process automation in the pharmaceutical industry. It discusses various pharmaceutical manufacturing processes like granulation, drying, milling, and compression. It also describes different types of pharmaceutical processing equipment used for unit operations like mixing, drying, milling etc. Finally, it discusses process automation and concepts like cleaning-in-place and sterilization-in-place which are important for ensuring sterility in pharmaceutical manufacturing.
SUPAC, BACPAC, Post Marketing SurveillanceMANIKANDAN V
This document discusses various guidelines related to product development and technology transfer in the pharmaceutical industry. It covers SUPAC, BACPAC, and post-marketing surveillance. SUPAC provides guidance for scale-up and post-approval changes, categorizing changes into different levels based on their potential impact. BACPAC guidance addresses post-approval changes for bulk active pharmaceutical ingredients. Post-marketing surveillance involves monitoring adverse drug events after approval to ensure ongoing safety and effectiveness.
This document discusses the validation of a fluidized bed dryer. It begins with an introduction to fluidized bed drying and the construction and working of fluidized bed dryers. It then discusses the four stages of validation for equipment: design qualification, installation qualification, operational qualification, and performance qualification. For each stage, it provides details on the specific tests and documentation required for validating a fluidized bed dryer. It emphasizes establishing that the dryer will consistently and reliably perform its intended functions.
A brief presentation on the current good manufacturing practices employed in the manufacture of pharmaceuticals in the US.
Comprises of all aspects of good manufacturing practices
This document outlines the key concepts and history of the process validation lifecycle approach. It discusses the development of the approach through various regulatory guidances from organizations like FDA, Health Canada, EMA, ICH, and PIC/S. The lifecycle approach involves three stages: process design, process qualification, and continued process verification. It represents a shift from a traditional approach of conducting process validation to one focused on continual process improvement and understanding over the entire product lifecycle. Implementation of the approach can be difficult for organizations.
Auditing of vendors and production departmentPRANJAY PATIL
The document discusses vendor audits in the pharmaceutical industry. It provides details on the objectives, parameters, and steps of conducting a vendor audit. The key points are:
- Vendor audits assess a vendor's quality management system, practices, documentation, and adherence to standards to ensure their products and services meet requirements.
- Important parameters reviewed include ISO certifications, manufacturing facilities, packaging and labeling standards, and data handling procedures.
- The goals are to evaluate quality control measures and management commitment to quality standards required by regulations.
- Conducting vendor audits helps reduce costs and risks by gaining insight into supplier processes and compliance.
This document provides an overview of qualification and validation principles according to Good Manufacturing Practices (GMP). It defines qualification and validation, and explains their scope, principles, types of documentation, and importance. Qualification and validation provide documented evidence that critical aspects of manufacturing are controlled. The document outlines the key elements that should be addressed in a validation master plan, protocol, and report. It also discusses new approaches to validation including risk assessment and a three-phase process design.
Air Based Hazards, M.pharm, sem 2,Bhumi Suratiya,.pptxBhumiSuratiya
Air Based Hazard, M.Pharm, Sem 2,Bhumi Suratiya, Pharmaceutical Quality Assurance. Source of air based hazard, types of air based hazard, air circulation maintenance for sterile and non sterile area . Application of air circulation, HEPA filter, clean area classification.
The document discusses the pharmaceutical industry development process in India. It outlines the legal requirements and licenses needed to manufacture or import APIs and drugs. Companies must seek approval from the DCGI and adhere to CDSCO guidelines. The application process requires submitting chemical, pharmaceutical, pre-clinical and clinical data. Various forms are used for obtaining manufacturing, import, and sales licenses from the CDSCO. The CDSCO-SUGAM project aims to streamline approval processes.
Sanitization & Hygiene in PharmaceuticalIqra Shafeeq
This document discusses sanitation and hygiene in the pharmaceutical industry. It outlines the importance of high sanitation standards across all aspects of manufacturing, including personnel, premises, equipment, materials and products. Specific hygiene practices for personnel are described, such as health examinations, illness reporting, protective clothing, and restrictions on eating or smoking in production areas. Design of premises and avoidance of cross-contamination through measures like segregated areas, ventilation, airlocks, clothing standards and cleaning validation are also covered. Production operation sanitation procedures including cleaning validation, water systems cleaning and maintenance activities are summarized.
The document discusses plastic packaging materials used for pharmaceutical products. It begins by describing the two main categories of plastics - thermoplastics and thermosets. It then discusses potential interactions between drugs and plastic packaging, including permeation, leaching, sorption, and chemical reactions. Finally, it covers various closure and sealing methods that are approved by the FDA as tamper resistant packaging systems for pharmaceuticals, such as blister packs, bubble packs, foil/plastic pouches, and bottle seals.
This document provides information about qualification of an autoclave. It defines qualification as proving that equipment works correctly and leads to expected results. It discusses different types of qualification including design, installation, operational, and performance qualification. For autoclave qualification, it outlines tests that should be performed at each stage like temperature mapping, alarm checks, steam penetration tests, and biological indicator testing to prove the autoclave is sterilizing properly. It also provides guidelines for safe operation of the autoclave.
This document discusses good manufacturing practices for manufacturing operations and controls in the pharmaceutical industry. It covers several key topics:
1. Sanitation of manufacturing premises is important to ensure good hygiene of facilities, equipment, processes, and personnel. Cleaning and validation procedures should be established and records maintained.
2. Proper controls must be established to prevent mix-ups and cross-contamination during production. This includes separation of products, labeling, cleaning procedures, and qualified personnel.
3. Waste and scrap from manufacturing must be properly handled, collected, stored, and disposed of according to established guidelines. Hazardous and pharmaceutical wastes require special treatment and disposal.
Audit of vendors and production departmentSanmati shete
The document presents checklists for tableting, capsule filling, and sterile preparation processes. It was created by Sanmati Dilip Shete, an M.Pharm. student in the Department of Quality Assurance at Rajarambapu College of Pharmacy. The checklists provide steps to ensure quality control for common pharmaceutical manufacturing processes like tablet production, capsule filling, and sterile compounding.
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
This document discusses sanitation and hygiene principles for manufacturing facilities. It covers maintaining high standards of sanitation for personnel, premises, equipment, materials and products. Personal hygiene measures include health checks for employees, training on hygiene practices, prohibiting illness or lesions in production areas. The design of premises and production operations must facilitate effective cleaning and prevent contamination. Personnel hygiene procedures like protective clothing and handwashing apply to all persons in production areas. Group activities involve identifying sanitation issues in photographs and key hygiene considerations for a new factory.
The document discusses quality management and good manufacturing practices (GMP) in the pharmaceutical industry. It defines quality management as determining and implementing quality policies through an appropriate quality system. GMP is described as ensuring products are consistently produced according to quality standards and marketing authorizations through defined processes and validated equipment and facilities. The key components of an effective GMP system include premises and equipment qualification, trained personnel, process and product testing, and documentation of manufacturing and distribution activities.
This document discusses documentation requirements for good manufacturing practices (GMP) according to WHO guidelines. It covers labeling requirements for containers, equipment, and premises. It also discusses specifications for starting materials, packaging materials, finished products, and intermediates. Master formulas and batch processing records are described. Standard operating procedures (SOPs) are discussed, including activities that require SOPs. Different types of records are outlined, including where they should be stored.
Clean Room Pharmaceutical Good Manufacturing Process.pdfHananZayed4
This document discusses cleanroom design and classification for pharmaceutical facilities. It begins by defining cleanrooms and their importance in industries like pharmaceuticals. It then explains cleanroom classification standards from ISO and PIC/S, which classify cleanrooms based on maximum allowable particle counts. The document outlines design considerations for cleanrooms, including airflow, materials, and features to enable cleaning. It emphasizes the importance of layouts and flow diagrams to design facilities that meet process, personnel, and material flow needs.
The document discusses cleanrooms and their classification systems according to ISO standards and PIC/S guidelines. It provides information on cleanroom design features and layout considerations for pharmaceutical manufacturing facilities. The key steps in sterile vial filling are outlined, and traditional cleanroom-based approaches are compared to newer isolator technologies that remove the operator from the sterile processing area.
Labels must clearly identify containers, equipment, and premises. Labels provide information like the product name, batch number, status, and cleaning status. Documentation includes specifications for starting materials, packaging materials, finished products, and intermediates. Batch records document production and packaging. Standard operating procedures describe activities like equipment operation and cleaning, personnel matters, and sampling. Records of materials, production, packaging, equipment, and quality control must be kept for a defined period.
The document discusses sanitation and hygiene principles for good manufacturing practices. It covers ensuring good sanitation for premises, personnel, equipment, processes, materials and containers. It also discusses measures to ensure good personal hygiene. Some key points include having health examinations for personnel and training them on hygiene practices. Facilities should be designed to prevent dirt buildup and allow for effective cleaning. Cross-contamination should be avoided through measures like segregated areas, ventilation systems, protective clothing, and validated cleaning procedures. Production operations must also follow sanitation procedures and keep detailed records.
The document discusses the basic principles of equipment as it relates to Good Manufacturing Practices (GMP). It outlines objectives like ensuring equipment is properly located, designed, constructed, adapted and maintained. Specific requirements are covered for pipes, balances, production equipment, quality control instruments, washing/cleaning equipment. Design must minimize risks of error and contamination. Equipment must be calibrated and cleaned on a scheduled basis. Current drawings must be maintained and defects addressed. Questions are provided about inspecting and qualifying various equipment types.
This document provides an overview and objectives of a training module on heating, ventilation and air conditioning (HVAC) systems for pharmaceutical manufacturing facilities. It discusses various HVAC design considerations and components including air filtration levels, airflow patterns, temperature and humidity control, dust control, and protecting the environment from exhaust air and fumes. The role of HVAC in preventing cross-contamination between production areas is also covered.
This document discusses principles of self-inspection and quality audits in pharmaceutical production. It covers objectives of self-inspection including identifying roles in quality management. Key areas to inspect include production procedures, equipment, materials handling, batch records, and deviations. Effective self-inspection requires defined teams, inspection programs, checklists, reports, and corrective action plans. External audits verify compliance and can include regulatory, contractor, or supplier audits. Auditors should evaluate self-inspection programs and ensure defined processes are followed.
The document provides an overview of heating, ventilation and air-conditioning (HVAC) systems in pharmaceutical manufacturing facilities. It discusses how HVAC systems can impact product quality, personnel comfort, and contamination control. The document outlines objectives to understand the need for HVAC, its role in protecting products, personnel and the environment from contamination, and its role in dust control. It also discusses HVAC system design, commissioning, qualification and maintenance.
The document discusses factors to consider for an efficient and effective engineering work area, including space, cleanliness, lighting, ventilation, hazardous materials, noise, vibration, electrical equipment, and fluid power equipment. Ensuring adequate consideration of each factor can help prevent accidents and contamination. Maintaining an organized, clean work area is essential for safety and productivity.
Tài liệu GMP được chia sẻ bởi GMPc Việt Nam - Nhà tư vấn Sáng tạo, Chuyên nghiệp, Toàn diện Dự án Nhà máy GMP (EU, PIC/S, WHO, ASEAN), ISO 13485:2012, ISO/IEC 17025:2005, ISO 15189:2012, ISO 15378:2011, ISO 9001:2008
This document provides information about cleanrooms, their classification, design, and testing. It defines cleanrooms and classifications based on maximum allowable particle concentrations. ISO classification ranges from 1 to 9, with lower numbers indicating cleaner rooms. Design considerations include personnel and material flows, air flow patterns to minimize contamination, construction materials for cleanability, and HVAC systems for air filtration and pressure differentials between zones. Parameters like particle levels, air changes, temperature and humidity are monitored regularly to maintain cleanroom quality.
This document provides an overview of good practices for chemicals management at chemical plants. It discusses good practices for core processes like synthesis and formulation, separation processes, equipment cleaning and maintenance, and storage. Specific practices include improving material efficiency, heat recovery, using enclosed cleaning systems, and computerized inventory management. The document also outlines challenges and good practices for infrastructure like boilers, cooling towers, heat exchangers, and pumps. Practices focus on improving energy efficiency, preventing leaks, reusing waste heat and water, and conducting regular maintenance.
Quy trình kiểm soát thay đổi sau khi cấp Giấy chứng nhận GMP/Giấy chứng nhận đủ điều kiện kinh doanh dược đối với cơ sở sản xuất thuốc, nguyên liệu làm thuốc
Quy trình đánh giá đáp ứng “Thực hành tốt sản xuất thuốc, nguyên liệu làm thuốc” (GMP) đối với cơ sở không thuộc diện cấp chứng nhận đủ điều kiện kinh doanh dược
This document lists 46 consulting projects completed or in progress by GMPc Vietnam Joint Stock Company between May 2011 and January 2024. The projects involve consulting services for clients seeking to establish, expand, or renovate pharmaceutical manufacturing facilities that meet Good Manufacturing Practice (GMP) standards set by the World Health Organization (WHO) and other regulatory bodies. Services provided include facility design, budgeting, training on GMP requirements, and assistance with drafting and finalizing GMP registration dossiers. Clients span the pharmaceutical, biotech, and healthcare industries in Vietnam.
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
1. Module 9 | Slide 1 of 46 2012
Premises
Part One
Basic Principles of GMP
12
2. Module 9 | Slide 2 of 46 2012
Premises
Objectives
1. To review general requirements
2. To list key requirements for site choice
3. To consider specific requirements for main areas
4. To list major facilities required in a multifunction site
3. Module 9 | Slide 3 of 46 2012
12.1
Premises
Principle
Important aspects to be kept in mind to ensure the suitability of
the operations to be carried out for different dosage forms and
product range:
Location
Design
Construction
Adaptation
Maintenance
4. Module 9 | Slide 4 of 46 2012
12.1, 12.4
Premises
Location
Geography, climate, noise and economic factors
Neighbouring factories and sites
What do they do?
What impact can they have on the
business?
Pollution/effluent control
Minimum risk for contamination of products and materials
5. Module 9 | Slide 5 of 46 2012
12.4
Premises
Principle
Premises must be
located, designed, and
with a layout to
minimize risks of
cross-contamination,
e.g. not located next
to a malting factory with
high airborne levels of
yeast
6. Module 9 | Slide 6 of 46 2012
12.2
Premises
General
The layout and design should aim to:
Avoid any adverse effect on the quality of products
Avoid cross-contamination, build-up of dirt and dust
Minimize risks of errors
Permit effective cleaning
Permit effective maintenance
7. Module 9 | Slide 7 of 46 2012
Premises
Design Principles
Ensure logical flow. Keep in mind:
Material flow
People flow
Process flow
(Look at the layouts and see how people, materials
and products flow)
12.10
8. Module 9 | Slide 8 of 46 2012
Q C Offices
Gowning
Canteen
Incoming
goods
Corridor
Corridor
Shipping
Corridor
Packaging
Weighing Processing
Filling
Raw
Materials
&
Packaging
Storage
Washing Machine
Shop
Finished
Products
Storage
Corridor
Utilities and Services Waste Treatment
Premises
Example of Materials and People Flow
Arrival of goods Entrance for visitors Entrance for Workers Shipment of goods
Material
Flow
People Flow
Zone: Clean
Zone: Packaging
Zone: Controlled
9. Module 9 | Slide 9 of 46 2012
12.5, 12.7, 12.9
Premises
Design
Suitable design and construction to facilitate good
sanitation
Cleaning and disinfecting according to detailed written
procedures – records maintained
Maximum protection against entry of insects, birds and
animals
Procedure for rodent and pest control implemented
10. Module 9 | Slide 10 of 46 2012
12.8, 12.32
Premises
Construction and utilities
Suitable construction materials
Electrical supply
Suitable lighting (especially for visual on-line checks)
Temperature and relative humidity
– Controlled, monitored and recorded
Appropriate and effective ventilation
These may affect products during manufacture or
storage as well as functioning of equipment
11. Module 9 | Slide 11 of 46 2012
Basic Principles of GMP
The temperature and
relative humidity should
be controlled, monitored
in accordance with an
SOP, and the results
recorded.
The limits should be
appropriate according to
the storage requirements
for materials and
products
12. Module 9 | Slide 12 of 46 2012
12.3
Premises
Construction
Dust generating operations
e.g. sampling, weighing, mixing, packing of
powders, etc.
Measures should be taken to prevent cross-
contamination
Measures to facilitate cleaning
– E.g. Materials of construction; ledges and edges; smooth
surfaces
13. Module 9 | Slide 13 of 46 2012
Basic Principles of GMP
Design of areas for
weighing of materials
Proper air supply
Dust control measures
(including extraction of dust
and air)
Easily cleanable surfaces
No areas for dust
accumulation
Protection of material,
product and operator
14. Module 9 | Slide 14 of 46 2012
12.6
Premises
Maintenance
Procedure for maintenance of the premises
Records maintained
Damage repaired
Repairs and maintenance should not present any
hazard to the quality of the products
What should be done if there is any damage while a
product is being processed?
15. Module 9 | Slide 15 of 46 2012
Basic Principles of GMP
16. Module 9 | Slide 16 of 46 2012
12.11 – 12.36
Premises
Specific areas
In Part 2 – we will review some recommendations for specific
areas such as:
Ancillary areas
Storage areas
Weighing areas
Production areas
Quality control areas
17. Module 9 | Slide 17 of 46 2012
Premises
Part two
Basic Principles of GMP
12
18. Module 9 | Slide 18 of 46 2012
12.11 – 12.14
Premises
Ancillary Areas
Rest and refreshment rooms: Separate from production and
quality control areas
Changing, washing and toilet areas accessible and appropriate
numbers
Animal houses well isolated – separate air handling and
entrance
Maintenance workshops: Separated from production - if not
possible – tools in reserved areas
19. Module 9 | Slide 19 of 46 2012
Basic Principles of GMP
TO
ILETS
AIR
LO
C
K
C
AN
TEEN
FAC
TO
R
Y
C
H
AN
G
E
R
O
O
M
20. Module 9 | Slide 20 of 46 2012
Basic Principles of GMP
21. Module 9 | Slide 21 of 46 2012
Basic Principles of GMP
Separate receiving
and dispatch bay
Protect materials and
products from
weather
Area to clean
incoming materials
provided
12.17
22. Module 9 | Slide 22 of 46 2012
Basic Principles of GMP
Cleaning of incoming
containers
Cleaning with a cloth, or
duster
Cleaning by using a
vacuum cleaner
Use of air curtains and
air tunnels
23. Module 9 | Slide 23 of 46 2012
12.15, 12.16
Premises
Storage areas - 1
Sufficient capacity, orderly storage of categories of
materials and products
Storage conditions
Separate and segregated areas
– starting materials, packaging materials, intermediates, bulk,
finished products, quarantined, released, rejected, returned
and recalled products and materials
24. Module 9 | Slide 24 of 46 2012
Basic Principles of GMP
25. Module 9 | Slide 25 of 46 2012
Basic Principles of GMP
26. Module 9 | Slide 26 of 46 2012
12.16
Premises
Storage areas - 2
Good storage conditions
– Clean
– Dry
– Temperatrure
– Lights
Within defined limits
Provided, controlled,
Monitored and recorded
27. Module 9 | Slide 27 of 46 2012
12.18 – 12.20, 12.22
Premises
Storage areas - 3
Separated areas recommended - clearly marked and access
restricted e.g.:
– Quarantine area
Segregate areas:
Rejected, recalled and returned materials and products
Separate sampling area recommended to prevent risk for
contamination or cross-contamination
Safe and secure areas for highly active, radioactive materials,
narcotics and other materials (risk of abuse, fire, explosion)
28. Module 9 | Slide 28 of 46 2012
Basic Principles of GMP
29. Module 9 | Slide 29 of 46 2012
12.21
Premises
Storage areas – 4
Printed packaging materials
Correct materials are critical to ensure compliance with correct
labelling of products
Ensure compliance with specifications, prevent mix-ups
Special attention to:
– Sampling
– safe and secure storage
30. Module 9 | Slide 30 of 46 2012
12.23
Premises
Weighing areas
Weighing operations – in separated areas
Appropriate design (see also training material on HVAC)
Provision for dust control
Smooth, impervious, durable, easy-to-clean finishes
Cleaning procedures and records
Documentation, e.g. SOPs, logs and records
31. Module 9 | Slide 31 of 46 2012
Basic Principles of GMP
32. Module 9 | Slide 32 of 46 2012
12.24
Premises
Production areas - 1
Minimize risk of cross-contamination:
Dedicated and self-contained facilities for some products such
as highly sensitizing materials (e.g. penicillins) or biological
preparations (e.g. live microorganisms)
Separate facilities for other products such as some antibiotics,
hormones, cytotoxic substances
Non-pharmaceuticals normally not in the same facility, e.g.
pesticides, herbicides
33. Module 9 | Slide 33 of 46 2012
12.32, 12.26, 12.31
Premises
Production areas -2
Layout in accordance with sequence of production (flow)
Layout to avoid mix-ups and cross-contamination
Orderly and logical positioning of equipment
minimizes risk of contamination, mix-ups and missing
production steps
Appropriate cleanliness level, and lights
Adequate work and in-process storage space
34. Module 9 | Slide 34 of 46 2012
12.32, 12.26, 12.31
Premises
Production areas -2
Specially designed areas for packaging
Layout
Space
No mix-ups
35. Module 9 | Slide 35 of 46 2012
12.27
Premises
Production areas - 3
Starting and packaging materials, intermediates and bulk
exposed to environment:
Interior surfaces (walls, floors, ceilings) – smooth, free from
cracks and open joints
No shedding of particles
Easy and effective cleaning permitted
Disinfection if needed
36. Module 9 | Slide 36 of 46 2012
12.28, 12.29
Premises
Production areas - 4
Design of pipework, light fittings, and ventilation points
– no recesses that are difficult to clean
Access for maintenance from outside production areas
Drains
– adequate size
– equipped to prevent back-flow
Open channels avoided
37. Module 9 | Slide 37 of 46 2012
Basic Principles of GMP
38. Module 9 | Slide 38 of 46 2012
12.30
Premises
Production areas - 5
Effective ventilation with air control facilities
Including filtration of air to a sufficient level to prevent
contamination and cross-contamination – also external
environment
Control of temperature and relative humidity where
necessary
Regular monitoring of conditions during production and non-
production periods
39. Module 9 | Slide 42 of 46 2012
12.33, 12.34
Premises
Quality Control areas - 1
QC laboratories should be separate from production areas
Separate areas for biological, microbiological and radioisotope
methods
Suitable design with sufficient space to avoid mix-ups and
cross-contamination
Suitable space for storage samples, reference standards,
solvents, reagents and records
40. Module 9 | Slide 43 of 46 2012
Basic Principles of GMP
41. Module 9 | Slide 44 of 46 2012
12.35, 12.36
Premises
Quality Control areas - 2
Suitable construction materials
Prevention of fumes
Ventilation
Separate air supply (production and QC)
Separate rooms for some instruments to protect them from
interference (e.g. electrical, vibration, moisture, etc.)
See supplementary training on QC laboratories
42. Module 9 | Slide 45 of 46 2012
Premises
Group Session - Option 1
A company wishes to manufacture simple, non-sterile
medicines. It has engaged a consultant to draw up some
building plans
Comment on the building plans “faxed” through to your group
Comment on the people flow, the process flow and the
material flow
43. Module 9 | Slide 46 of 46 2012
Premises
Group Session - Option 2
Consider a multifunction factory producing sterile and non-
sterile products:
What GMP facilities would you expect to find in this
factory?
What would you look for in the quality of those facilities
and what weaknesses might you find?
How can companies overcome those weaknesses?
Editor's Notes
21 September, 2021
21 September, 2021
21 September, 2021
21 September, 2021
21 September, 2021
21 September, 2021
21 September, 2021
21 September, 2021
21 September, 2021
21 September, 2021
21 September, 2021
21 September, 2021
21 September, 2021
Maintenance workshops should be separated from production areas. If tools are to be kept in a manufacturing area, then they should be placed in a
container or cupboard specific for that purpose.
Animal houses should be isolated from all other areas with separate entry and air-handling facilities to prevent any risk of cross-contamination